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Both neuronal acetylcholine and nonneuronal acetylcholine have been demonstrated to modulate inflammatory responses.
Studies investigating the role of acetylcholine in the pathogenesis of bacterial infections have revealed contradictory findings
with regard to disease outcome. At present, the role of acetylcholine in the pathogenesis of fungal infections is unknown. There-
fore, the aim of this study was to determine whether acetylcholine plays a role in fungal biofilm formation and the pathogenesis
of Candida albicans infection. The effect of acetylcholine on C. albicans biofilm formation and metabolism in vitro was assessed
using a crystal violet assay and phenotypic microarray analysis. Its effect on the outcome of a C. albicans infection, fungal bur-
den, and biofilm formation were investigated in vivo using a Galleria mellonella infection model. In addition, its effect on mod-
ulation of host immunity to C. albicans infection was also determined in vivo using hemocyte counts, cytospin analysis, larval
histology, lysozyme assays, hemolytic assays, and real-time PCR. Acetylcholine was shown to have the ability to inhibit C. albi-
cans biofilm formation in vitro and in vivo. In addition, acetylcholine protected G. mellonella larvae from C. albicans infection
mortality. The in vivo protection occurred through acetylcholine enhancing the function of hemocytes while at the same time
inhibiting C. albicans biofilm formation. Furthermore, acetylcholine also inhibited inflammation-induced damage to internal
organs. This is the first demonstration of a role for acetylcholine in protection against fungal infections, in addition to being the
first report that this molecule can inhibit C. albicans biofilm formation. Therefore, acetylcholine has the capacity to modulate
complex host-fungal interactions and plays a role in dictating the pathogenesis of fungal infections.
Bloodstream infections caused byCandida species remain a fre-quent cause of morbidity and mortality, particularly within
the immunocompromised population (1, 2). Candida albicans is
an opportunistic pathogen that causes both superficial and sys-
temic infections and is the main causative organism responsible
for systemic candidiasis. Virulence factors that contribute to C.
albicans pathogenicity include hypha formation, the expression of
cell surface adhesins and invasins, and the development of bio-
films (3). If untreated, a progressive C. albicans infection can lead
to a dysregulated host inflammatory response that damages in-
fected organs and leads to sepsis (4).
The cholinergic anti-inflammatory pathway regulates immune
responses to pathogens and is mediated by acetylcholine (ACh)
(5). ACh released from efferent vagus nerve terminals interacts
with the alpha 7 nicotinic receptor (7nAChR) on proximal im-
mune cells, resulting in downregulated localized immune re-
sponses. In addition, the efferent vagus nerve interacts with the
splenic nerve to activate a unique ACh-producing memory phe-
notype T-cell population that can propagate ACh-mediated im-
munoregulation throughout the body (6). Furthermore, ACh is
produced by numerous cells outside of neural networks, and non-
neuronal ACh can also play a vital role in immune regulation
through its cytotransmitter capabilities (7, 8).
Investigations into the role of the “cholinergic anti-inflamma-
tory pathway” in bacterial infections have revealed contradictory
findings. Vagus nerve stimulation attenuated systemic inflamma-
tory responses to bacterial endotoxin (5), and ACh attenuated
endotoxin-induced release of proinflammatory cytokines (e.g.,
tumor necrosis factor [TNF] and interleukin-1 [IL-1]) but not
anti-inflammatory cytokines (e.g., IL-10) from macrophages (9).
Furthermore, 7nAChR/ mice infected with Escherichia coli
developed more severe lung injury and had higher mortality rates
than 7nAChR/ mice (10), and 7nAChR activation attenu-
ated systemic inflammation in a polymicrobial abdominal sepsis
model (11). In contrast, activation of the “cholinergic anti-inflam-
matory pathway” had a detrimental effect on disease outcome in
mouse models of E. coli-induced peritonitis (12) and pneumonia
(13), as well as stroke-induced Pseudomonas aeruginosa lung in-
fection (14). Therefore, the role ACh plays in the pathogenesis of
bacterial disease depends on the site of infection and etiological
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agent. Furthermore, ACh synthesis has also been demonstrated in
bacteria and fungi (15, 16). Cholinergic communication and reg-
ulation have been established to exist in these primitive unicellular
organisms (15, 17). However, the receptors that mediate the re-
sponse ofmicroorganisms toACh are notwell characterized.Nev-
ertheless, the role that host-derived ACh plays in modulating the
growth and pathogenicity of microorganisms is unknown.
To date, no study has investigated the role of ACh in fungal
infections, and the functional relationship between ACh and C.
albicans biofilm formation and pathogenicity remains to be deter-
mined. Therefore, the aim of this studywas to determine the effect
of ACh onC. albicans growth and biofilm formation, as well as the
role of ACh in modulating host innate immune responses during
C. albicans infection.
MATERIALS AND METHODS
Candida albicans culture. Candida albicans SC5314 was subcultured
onto Sabouraud dextrose agar (SAB) (Sigma-Aldrich, Dorset, United
Kingdom) and stored at 4°C until required. For the experiments de-
scribed, C. albicans was propagated in yeast extract-peptone-dextrose
(YPD) medium (Sigma-Aldrich, Dorset, United Kingdom), washed by
centrifugation, and resuspended in either yeast nitrogen base (YNB) me-
dium (Sigma-Aldrich, Dorset, United Kingdom) or RPMI 1640 medium
(Life Technologies, Paisley, United Kingdom) to the desired concentra-
tion, as described previously (18).
Crystal violet assay and phenotypic microarray analysis. Biofilm
biomass of C. albicans cultured in RPMI for 24 h was quantified using the
crystal violet assay, as previously described (18). Real-time cellular meta-
bolic activity (respiration) was evaluated using phenotypic microarray
(PM) analysis as previously described (19). Briefly, a suspension of C.
albicans was adjusted to a transmittance of 62% (5  106 cells · ml1)
using a turbidimeter. Cell suspensions for the inoculums were then pre-
pared in IFY buffer (Biolog, Hayward, CA), and the final volume was
adjusted to 3 ml using reverse osmosis (RO) sterile distilled water. Ninety
microliters of this cell suspension was then inoculated into each well of a
Biolog 96-well plate (Biolog). Anaerobic conditions were generated by
placing each plate into a PMgas bag (Biolog) and vacuumpacked using an
Audion VMS43 vacuum chamber (Audion Elektro BV, Netherlands). An
OmniLog reader (Biolog) was used to photograph the plates at 15-min
intervals to measure dye conversion, and the pixel intensity in each well
was then converted to a signal value reflecting cell metabolic output.
Galleria mellonella killing assay. The pathogenicity of C. albicans, in
the presence and absence of ACh, was assessed using the G. mellonella
killing assay (20, 21). Sixth-instar G. mellonella larvae (Livefoods Direct,
Ltd., United Kingdom)with a bodyweight of between 200 to 300mgwere
used in the study. Larvae were inoculated into the hemocoel with C. albi-
cans (5  105 cells/larva), in the presence and absence of ACh (50 g/
larva), through the hindmost proleg, using a 50-l Hamilton syringe with
a 26-gauge needle. In addition, larvae inoculatedwith phosphate-buffered
saline (PBS) and ACh alone (50 g/larva) were included for control pur-
poses. For each experiment, 10 larvae were inoculated for each experi-
mental group. The inoculated larvae were placed in sterile petri dishes and
incubated at 37°C, and the number of dead larvaewas scored daily. A larva
was considered deadwhen it displayed nomovement in response to touch
together with a dark discoloration of the cuticle. The experiment was
repeated on 3 independent occasions.
RNAandDNAextraction.Larvaewere inoculated as described above.
At both 4 h and 24 h postinfection, 3 larvae from each experimental group
were snap-frozen in liquid nitrogen and ground to a powder by mortar
and pestle in TRIzol (Invitrogen, Paisley, United Kingdom). The samples
were further homogenized using a bead beater, and RNAwas extracted as
described previously (18). To extract DNA from the same sample, 250 l
back extraction buffer (4 M guanidine thiocyanate, 50 mM sodium ci-
trate, 1MTris [pH 8.0]) was added to the phenol- and interphase, and the
mixtures were incubated at room temperature for 10 min. Samples were
then centrifuged at 12,000  g for 15 min at 4°C. The upper phase was
removed, and an equal volume of 100% isopropanol was added, after
which the samples were incubated overnight at80°C. After incubation,
samples were centrifuged at 12,000 g for 15min at 4°C. The supernatant
was removed, and the pellets werewashed 3 timeswith 70% ethanol. DNA
was eluted in a final volume of 50 l Tris EDTA (10 mM Tris, 0.1 mM
EDTA [pH 8.0]). The experiment was repeated on 3 independent occa-
sions.
Gene expression analysis. RNA was quantified and quality assessed
using a NanoDrop spectrophotometer (ThermoScientific, Loughbor-
ough, United Kingdom). cDNAwas synthesized from 200 ng of extracted
RNA using a Life Technologies high-capacity RNA to cDNA kit (Life
Technologies, Paisley, United Kingdom) in a MyCycler PCR machine
(Bio-Rad Laboratories, Hertfordshire, United Kingdom), following the
manufacturer’s instructions. All primers used for quantitative PCR
(qPCR) studies are shown in Table 1. The cycling conditions consisted of
2 min at 50°C, 10 min at 95°C, and 40 cycles of 15 s at 95°C and 60 s at
60°C. Each sample was analyzed in duplicate using an MxProP qPCR





ALS3 Forward CAACTTGGGTTATTGAAACAAAAACA 21
Reverse AGAAACAGAAACCCAAGAACAACCT
HWP1 Forward GCTCAACTTATTGCTATCGCTTATTACA 21
Reverse GACCGTCTACCTGTGGGACAGT
ACT1 Forward AAGAATTGATTTGGCTGGTAGAGA 21
Reverse TGGCAGAAGATTGAGAAGAAGTTT
18S Forward CTCGTAGTTGAACCTTGGGC Unpublished
Reverse GGCCTGCTTTGAACACTCTA
G. mellonella
Gallerimycin Forward GAAGATCGCTTTCATAGTCGC 45
Reverse TACTCCTGCAGTTAGCAATGC
Galiomicin Forward CCTCTGATTGCAATGCTGAGTG 45
Reverse GCTGCCAAGTTAGTCAACAGG
-Actin Forward GGGACGATATGGAGAAGATCTG 45
Reverse CACGCTCTGTGAGGATCTTC
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machine and MxProP 3000 software (Stratagene, Amsterdam, Nether-
lands). No-reverse transcriptase (no-RT) and no-template controls were
included. Gene expression was calculated by the threshold cycle (	CT)
method (22).
Fungal burden.DNAwas quantified and quality assessed using a Nano-
Drop spectrophotometer (ThermoScientific, Loughborough, United King-
dom). Colony-forming equivalents (CFE) of C. albicanswere determined
by 18S real-time PCR as described previously (23). The primer sequences
are shown in Table 1. The PCR cycling conditions were as follows: 2 min
at 50°C, 10min at 95°C, and 40 cycles of 15 s at 95°C and 60 s at 60°C. Each
sample was analyzed in duplicate using an MxProP qPCR machine and
MxProP 3000 software (Stratagene, Amsterdam, Netherlands). No-tem-
plate controls were included. An analysis of nucleic acid extracted from
serially titratedC. albicanswas run in conjunctionwith each set of samples
to quantify the fungal burden.
Hemocyte count. Larvae were inoculated as described previously.
However, to ensure the larvae survived for
72 h, a lower inoculum of C.
albicans (1 105 cells/larvae) was used. At 24, 48, and 72 h postinocula-
tion, 3 randomly selected larvaewere bled and the hemolymphwas pooled
into a prechilled microcentrifuge tube containing a few granules of N-
phenylthiourea (Sigma-Aldrich) to prevent melanization (24). The total
hemolymph volumewasmeasured.Hemocyteswere recovered by centrif-
ugation (1,500  g for 3 min) and resuspended in 100 l of trypan blue
(0.02% in PBS). Samples were incubated at room temperature for 10min,
and viable hemocytes were enumerated using a Neubauer hemocytome-
ter. The experiment was repeated on 3 independent occasions.
Cytospin assay. Larvae were inoculated for hemocyte counts as de-
scribed above. At 24, 48, and 72 h postinoculation, 100 l of circulat-
ing hemolymph was extracted from 3 randomly selected larvae in each
experimental group and diluted 1:1 in PBS prior to cytocentrifugation
at 600 rpm for 5 min. Cytospin slides were fixed with Cytofix and
stained with hematoxylin and eosin. Image acquisition was performed
by the NanoZoomer-XRC12000 series (Hamamatsu Photonics K.K., To-
kyo, Japan). The experiment was repeated on 3 independent occasions.
Larval histology. After hemolymph extraction, the same larvae were
processed for histology as previously described (25). Briefly, the larvae
were inoculated with buffered formalin and processed by means of trans-
verse-cut serial sections. Tissue sections were stained with hematoxylin
and eosin, periodic acid-Schiff stain (PAS), and Giemsa stain, and exam-
ined by a technician and a pathologist. Image acquisition was performed
by the NanoZoomer-XR C12000 series (Hamamatsu Photonics, Tokyo,
Japan). The experiment was repeated on 3 independent occasions.
Lysozyme assay.The lysozyme assay was performed following amod-
ification of the method described by Shugar (26). Briefly, the hemolymph
of 3 randomly selected larvae from each experimental groupwas collected
on ice, and the weight was ascertained prior to dilution by addition of 50
l of 66 mM potassium phosphate buffer (PPB), pH 6.24, at 25°C. The
suspension was then centrifuged, and hemocytes were separated for enu-
meration using a Neubauer hemocytometer. Twenty-five microliters of
the remaining hemolymphwas then added to a suspension ofMicrococcus
lysodeikticus at 0.01% (wt/vol) in 66 mM PPB, and the reduction in tur-
bidity was measured at 450 nm every 5 min. The hemolymph lysozyme
concentration was calculated as follows: U/ml  [1,000 (	A450 test 
	A450 blank)/min]/[sample (ml)  dilution]. The lysozyme concentra-
tion was then adjusted for the number of hemocytes. The experiment was
repeated on 3 independent occasions.
Hemolytic (gallysin) assay. The ability of hemolymph (gallysins) to
lyse sheep red blood cells (RBC) was determined using a modification of
the method described by Beresford et al. (27). Briefly, packed sheep RBC
in Alsever’s solution were centrifuged and washed in glycerol–Veronal-
buffered saline at pH 7.4. (Sigma, Poole, United Kingdom). The cells were
then suspended to 108 cells/ml in dextrose–glycerol–Veronal-buffered
saline. Serial dilutions of hemolymph (collected as described above) start-
ing with 1 l of hemolymph diluted in a total of 100 l of dextrose–
glycerol–Veronal-buffered saline were combined with 100l of sheep red
blood cells and incubated at 37°C for 60 min. After incubation, the sam-
ples were placed on ice, 2 ml saline was added, and the supernatant was
centrifuged. The proportion of cells lysed by each dilution was compared
to that in a negative control containing no hemolymph and a positive
control in which all of the cells were lysed by the addition of 2 ml water.
From this, hemolytic units were determined as follows: no. of hemolytic
units/RBC  ln[1  (% lysis/100)]. The experiment was performed
using hemolymph from 3 larvae in each experimental group and repeated
on 3 independent occasions.
Statistical analysis.Graph production, data distribution, and statisti-
cal analysis were performed using GraphPad Prism (version 4; La Jolla,
CA). After ensuring the data conformed to a normal distribution, before
and after data transformation, analysis of variance (ANOVA) and t tests
were used to investigate significant differences between independent
groups. TheG.mellonella survival curvewas analyzed using a log rank test.
In the case of the gallysin assay, the slopes of each titrationwere surrogates
for average values. A Bonferroni correction was applied to all P values to
account for multiple comparisons of the data sets. Student t tests were
used to measure statistical differences between two independent groups
assessed in gene expression studies. Statistical significance was achieved if
P was0.05.
RESULTS
Acetylcholine inhibits Candida albicans biofilm formation in
vitro. C. albicans biofilm formation has been increasingly recog-
nized as a key mechanism of growth and survival in the host (3).
Therefore, we initially investigatedwhetherAChhad an impact on
C. albicans biofilm formation in vitro. Crystal violet assays re-
vealed a dose-dependent decrease in C. albicans biofilm biomass
when cultured in RPMI (hypha-inducing medium) plus ACh
compared toRPMI alone (Fig. 1A). Amaximum70.6% (P 0.01)
reduction in biomass was observed with 50 mg/ml of ACh, fol-
lowed by 54.5% (P 0.01), 42% (P 0.01), and 30.7% (P 0.01)
reductions with 12.5, 3.1, and 0.8 mg/ml of ACh, respectively.
To further investigate the impact of ACh on C. albicans phe-
notype, cellular respiration was assessed by phenotypic microar-
ray (PM) analysis over a 72-h period when cultured in RPMI or
YNB (non-hypha-inducing medium)  ACh. The raw data for
the PM analysis are shown in Fig. S1 in the supplemental material.
Graphical representations of the PM analysis revealed that there
was no significant effect on C. albicans cellular respiration at 24 h
(Fig. 1B), 48 h (Fig. 1C), or 72 h (Fig. 1D) when cultured in YNB
with concentrations of ACh ranging from 0.8 to 50 mg/ml. In
contrast, significant reductions in cellular respiration were ob-
served when C. albicans was cultured in RPMI with 12.5, 25, and
50 mg/ml ACh at 24 h (Fig. 1B), 48 h (Fig. 1C), or 72 h (Fig. 1D)
(all P values of0.05). However, as changes in cellular respiration
are associated with biofilm formation, this phenomenon could be
accredited to the inhibition of biofilm formation demonstrated in
Fig. 1A. Indeed, none of the concentrations of ACh used in this
study were found to be cytotoxic to C. albicans when cultured in
RPMI or YNB (data not shown).
Collectively, these data suggest that ACh is not fungicidal at the
concentrations used in this study and instead can inhibit the abil-
ity of C. albicans to form biofilms in vitro.
Acetylcholine prolongs the survival of Candida albicans-in-
fected Galleria mellonella larvae and reduces fungal burden.
Biofilm formation is associated withC. albicans pathogenicity (3).
Therefore, the effect of ACh on C. albicans pathogenicity in vivo
was investigated using a G. mellonella killing assay.
Inoculation of larvae withC. albicanswas shown to kill
80%
within 24 h (P  0.001) and 100% within 48 h (P  0.001)
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(Fig. 2A). Conversely, larvae treated with C. albicans plus ACh
(50 g/larva) exhibited only 25% (P 0.05) mortality within 48
h, and
60% remained alive after 72 h (Fig. 2A). The log rank test
revealed a statistically significant difference in survival of larvae
inoculated with C. albicans plus ACh in comparison to larvae in-
oculated with C. albicans alone (P  0.001). Control larvae, in-
jected with PBS or ACh (50g/larva) alone, exhibited 0%mortal-
ity at 72 h (Fig. 2A). Therefore, these data suggest that ACh
protects G. mellonella larvae from C. albicans-induced mortality.
To determine whether this protection against mortality was
due to the effect of ACh on fungal growth in vivo, fungal burden
was assessed using a qPCR-based assay. Four hours postinocula-
tion, the fungal burden of larvae inoculated with C. albicans alone
or C. albicans plus ACh showed no significant differences (Fig.
2B). However, 24 h postinoculation, the fungal burden of larvae
inoculated with C. albicans plus ACh was significantly reduced
15.6-fold (P 0.05) compared to that in larvae inoculated withC.
albicans alone (Fig. 2B).
These data suggest that the inoculation with ACh significantly
reduces the fungal biomass in vivo, which in turn prolongs the
survival of infected larvae.
Acetylcholine downregulates expression of Candida albi-
cans biofilm-associated genes in vivo. To test the hypothesis that
ACh impactsC. albicans biofilm formation in vivo, we investigated
the expression of two genes known to be important in biofilm
formation—HWP1 (the hyphal cell wall protein 1 gene) andALS3
(the agglutinin-like sequence 3 gene) (28).
Four hours postinoculation, the levels of expression of HWP1
and ALS3were significantly reduced 5.1-fold (P 0.05) (Fig. 2C)
and 1.6-fold (P  0.05) (Fig. 2D), respectively, in larvae inocu-
lated with C. albicans plus ACh compared to the levels in larvae
inoculated with C. albicans alone. At 24 h postinoculation, the
reduced expression of HWP1 was maintained at 4.9-fold (P 
0.05) in larvae inoculated withC. albicans plus ACh (Fig. 2C), and
the expression of ALS3was further reduced to 9.5-fold (P 0.05)
(Fig. 2D). Therefore, decreased expression of these genes suggests
that ACh can inhibit C. albicans hyphal growth and biofilm for-
mation in vivo.
Acetylcholine affects the pathogenesis of Candida albicans
infection in vivo. To visualize the ability of ACh to inhibit C.
albicans biofilm formation in vivo and to begin to investigate the
role of ACh in the pathogenesis of C. albicans infection, histolog-
ical analysis was performed.
Forty-eight hours postinoculation, both sham PBS inoculation
(Fig. 3A) and inoculationwith ACh alone (Fig. 3B) had no effects on
larval tissues. However, larvae inoculated with C. albicans alone ex-
hibited microvacuolization of the fat body and an increase in he-
mocytes in larval tissues, such as the fat body and the subcuticular,
FIG 1 Effects of acetylcholine onCandida albicans biofilm formation andmetabolic activity in vitro. (A) Crystal violet assessment ofC. albicans biomass after 24
h of growth in RPMI 1640 containing different concentrations of ACh (0 to 50 mg/liter). (B, C, and D) Graphical representations of phenotypic microarray
analysis of C. albicans respiration during culture in RPMI and YNB for 24 h (B), 48 h (C), and 72 h (D) in the presence of different concentrations of ACh (0 to
50mg/liter). All data are derived from triplicates of each condition performed in 3 independent experiments (n 3). *, P 0.05; **, P 0.01; and ***, P 0.001.
Acetylcholine Protects against Candida albicans
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intestinal, and paratracheal areas, in line with previously reported
findings (21). Furthermore, the presence of nodules and multifo-
calmelanizationwas also observed, as wereC. albicans hyphae that
exhibited signs of extracellular matrix deposition around intestinal
tissues and invasion of the gut walls (Fig. 3C, black circle) (see Fig. S2
in the supplemental material). In contrast, larvae inoculated with C.
albicans plus ACh presented with smaller nodules, which were
limited to peripheral larval tissues with no involvement of the gut
FIG2 Effects of acetylcholine on survival ofGalleriamellonella larvae afterCandida albicans infection and the ability ofCandida albicans to form a biofilm in vivo.
(A) Kaplan-Meier plot showing the effect of ACh on the survival of Candida albicans-infected larvae. The data are derived from three independent experiments
with groups of 10 larvae (n 30). ***, P 0.001, as determined by the log rank test in comparison to larvae inoculated withC. albicans alone. (B) Real-time PCR
determination of the effects of ACh on larval fungal burden as determined by colony-forming equivalents (CFE). Data are derived from 3 larvae from each
experimental group from 3 independent experiments (n  9). (C and D) Real-time PCR determination of the effects of ACh on expression of key Candida
albicans genes involved in dimorphic switching in vivo: hyphal cell wall protein 1 geneHWP1 (C) and agglutinin-like sequence 3 geneALS3 (D). Data are derived
from 3 larvae from each experimental group from 3 independent experiments (n 9). *, P 0.05.
FIG 3 Effects of acetylcholine on Candida albicans biofilm formation and host immunity in vivo. Histological analysis of larvae was performed using periodic
acid-Schiff (PAS) staining (A to D) and Giemsa staining (E to H) at 48 and 72 h postinoculation. The control groups are larvae inoculated with PBS (A and E)
or ACh (B and F) alone. Black circles highlightCandida albicans biofilm formation in panels C andG and nodule formation, which is representative of hemocyte
recruitment and activation, in panels D, G, andH. Representative images are shown from histological analysis of 3 larvae for each condition from 3 independent
experiments. Fb, fat body; Ct, cuticle; GI, gastrointestinal tract; T, trachea; Nd, nodule. Scale bars, 100 m.
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and tracheal systems. Furthermore, there was a significant reduc-
tion in melanization, and no hyphae were present (Fig. 3D, black
circle).
Seventy-two hours postinoculation, both sham PBS inocula-
tion (Fig. 3E) and inoculation with ACh alone (Fig. 3F) had no
effects on larval tissues. However, larvae infected with C. albicans
alone revealed extensive invasion of the intestinal walls and lu-
men, as well as the tracheal systems. Large nodules were also pres-
ent at sites of infection and in the fat body (Fig. 3G, black circle). In
contrast, larvae infected with C. albicans plus ACh exhibited de-
creased inflammation and less aggressive fungal infiltration of vi-
tal larval tissues, with only small melanized nodules present in the
subcuticular areas. In addition, C. albicans hypha formation was
not observed, and microvacuolization of the fat body was less
appreciable, with a return to nearly normal conditions suggestive
of resolution (Fig. 3H, black circle).
The histological evidence adds weight to the hypothesis that
ACh can inhibitC. albicans biofilm formation in vivo. In addition,
the data also suggest that ACh can also modulate host cellular
immune responses against C. albicans.
Acetylcholine modulates Galleria mellonella hemocyte re-
sponses toCandida albicans infection.To investigate further the
effect of ACh on host cellular immune responses during C. albi-
cans infection hemocyte counts, cytospin analysis and examina-
tion of larval histology were performed.
Hemocyte counts revealed that larvae inoculated with C. albi-
cans alone exhibited a significant 2-fold reduction in the number
of circulating hemocytes compared to control larvae 24 h postin-
oculation (P 0.05) (Fig. 4A).However, in larvae inoculatedwith
C. albicans plus ACh, circulating hemocyte numbers were reduced
17-fold (P  0.01) compared to those in control larvae and re-
duced 8-fold (P 0.05) compared to the level in larvae inoculated
with C. albicans alone. Furthermore, inoculation with ACh alone
induced a 4-fold reduction (P  0.01) in circulating hemocytes
compared to control larvae (Fig. 4A).
Forty-eight hours postinoculation, the significant 2-fold de-
crease in circulating hemocyte numbers observed at 24 h persisted
in C. albicans-inoculated larvae compared to control larvae (P
0.05) (Fig. 4A). However, in larvae inoculated with C. albicans
plus ACh, hemocyte numbers increased from those observed at 24
h, and as such, there was now only a 2-fold reduction (P 0.01) in
comparison to control larvae. A similar finding was observed in
larvae inoculated with ACh alone compared to control larvae (2-
fold reduction [P 0.01]) (Fig. 4A).
Seventy-two hours postinoculation, in larvae inoculated with
ACh alone orC. albicans plusACh, the number of circulating hemo-
cytes continued to rise, and as such, there were no significant differ-
ences between either condition and control larvae. In contrast, larvae
inoculated with C. albicans alone showed a 3.5-fold decrease in
circulating hemocytes compared to control larvae (P 0.01).
Furthermore, larvae inoculated with C. albicans alone also ex-
hibited a significant 1.4-fold decrease in circulating hemocytes
compared to larvae inoculated with C. albicans plus ACh (P 
FIG 4 Effects of acetylcholine on Candida albicans-induced hemocyte recruitment and activation. (A) Effect of ACh on hemolymph hemocyte counts. Data are
expressed as cells per milliliter of hemolymph. The bars represent the mean and standard deviations for at least 3 larvae from 3 independent experiments. *, P
0.05; **, P 0.01; ***, P 0.001. (B) Effect of ACh on C. albicans-induced hemocyte activation as determined by cytospin analysis. Representative images are
shown from cytospin analysis of 3 larvae for each condition from 3 independent experiments. Cytosopin analysis for each condition was performed 24 h (i to iv),
48 h (v to viii), and 72 h (ix to xii) postinoculation. Black arrows highlight small aggregates with melanin deposition. A white arrow highlights pronounced
aggregation, melanization, and merger of hemocytes into nodules with tissue-like structures. Asterisks highlight homogenous distribution of polymorphic
hemocytes immersed in an eosinophilic extracellular matrix. Scale bars, 100 m.
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0.01) and a 1.5-fold decrease compared to larvae inoculated with
ACh alone (P 0.001) (Fig. 4A).
Cytospin analysis revealed that 24 h postinoculation, hemo-
cytes from C. albicans-infected larvae (Fig. 4Biii, black arrow)
showed small aggregates with melanin deposition (black arrow)
compared to controls (Fig. 4Bi). A similar degree of aggregation
was observed by hemocytes from larvae inoculated with ACh
alone (Fig. 4Bii, black arrow). However, aggregation was more
pronounced in hemocytes isolated from larvae infected with C.
albicans plus ACh (Fig. 4Biv, black arrows).
Forty-eight hours postinoculation, hemocytes from larvae in-
oculated with ACh alone (Fig. 4Bvi) or C. albicans plus ACh (Fig.
4Bviii) showed aggregation in a monolayer with less appreciable
nodules. Moreover, in larvae inoculated with C. albicans plus
ACh, hemocytes showed pronounced aggregation, and hemocytes
merged into nodules with tissue-like structures (Fig. 4Bviii, white
arrow) in comparison to larvae infected with C. albicans alone
(Fig. 4Bvii). In addition, hemocytes from larvae inoculated with
ACh alone (Fig. 4Bvi) orC. albicans plus ACh (Fig. 4Bviii) showed
a homogenous distribution of polymorphic hemocytes immersed
in an eosinophilic extracellular matrix (asterisk).
Seventy-two hours postinfection, hemocytes from larvae inocu-
lated with C. albicans alone (Fig. 4Bxi) demonstrated complete ag-
gregation in a sole dense tissue-like sheet. In contrast, hemocytes
from larvae inoculatedwith ACh alone (Fig. 4Bx) orC. albicans plus
ACh (Fig. 4Bxii) were starting to disaggregate into single hemocytes.
Histological analysis of hemocyte recruitment in vivo (Fig. 5)
revealed that in larvae inoculated with ACh alone, only a few he-
mocytes are recruited around the tracheal tree at 24 h and 48 h
(Fig. 5B and F), with normal larval histology appreciable at 72 h
(Fig. 5J). In larvae inoculated with C. albicans alone, progressive
hyphal invasion can be easily observed around the trachea and gut,
with progressively extensive hemocyte recruitment 24 to 72 h
postinoculation (Fig. 5C, G, and K, black arrows). In contrast, in
larvae inoculated with C. albicans plus ACh, hemocyte aggrega-
tion into nodules (Fig. 5H, black asterisk) is observed 24 to 48 h
postinoculation, and no hyphal invasion of vital tissues is appre-
ciable (Fig. 5D and H). Furthermore, 72 h postinoculation, nod-
ules have disaggregated, and tissue homeostasis occurs with no
appreciable signs of infection (Fig. 5L).
In combination, the hemocyte counts, cytospin analysis, and
histology suggest that ACh can induce rapid activation of hemo-
cytes. Furthermore, the evidence suggests that ACh can promote
rapid clearance of C. albicans in vivo. Therefore, ACh may be an
important regulator of cellular immunity, and thismay be another
mechanism by which ACh protects larvae against C. albicans-in-
duced mortality.
Acetylcholine induces transient downregulation inCandida
albicans-induced expression of host antifungal peptides in vivo.
In mammalian systems, ACh has been shown to inhibit the hu-
moral armof the innate immune response (5, 7). To determine the
effect of ACh on humoral components of insect innate immunity,
we first used qPCR analysis to investigate expression of antifungal
peptides in vivo.
Four hours postinoculation, in comparison to PBS-inoculated
controls, expression of gallerimycin and galiomicin was signifi-
cantly upregulated 2-fold and 4-fold, respectively, in larvae inoc-
ulated with C. albicans alone (both P  0.05) (Fig. 6A and B).
However, in larvae inoculated with C. albicans plus ACh, expres-
sion of gallerimycin and galiomicin was significantly downregu-
lated 9-fold and 5-fold, respectively, compared to expression in
larvae inoculated with C. albicans alone (both P 0.001) (Fig. 6A
and B). Twenty-four hours postinoculation, no significant differ-
ences in gallerimycin or galiomicin expression were found be-
tween larvae inoculated with C. albicans alone and those inocu-
lated with C. albicans plus ACh (Fig. 6A and B). Interestingly, in
larvae inoculated with ACh alone, expression of both gallerimycin
and galiomicin was decreased in comparison to that in control
larvae (Fig. 6A and B) at 24 h; however, this was not found to be
statistically significant. Altogether, the data suggest that ACh can
transiently inhibit the expression of antifungal peptides.
Acetylcholine induces a transient downregulation in Can-
dida albicans-induced hemolymph gallysin activity. At present,
there are no functional assays for gallerimycin and galiomicin ac-
FIG 5 Effects of acetylcholine onCandida albicans-induced hemocyte recruitment intoGalleriamellonella tissues. Histological analysis of hemocyte recruitment
into larval tissues was performed using PAS staining 24, 48, and 72 h postinoculation. The control groups are larvae inoculated with PBS (A, E, and I) or ACh (B,
F, and J) alone. Larvae inoculated with C. albicans alone (C, G, and K) and C. albicans plus ACh (D, H, and L) are also represented. Extensive hemocyte
recruitment is highlightedwith black arrows. Hemocyte nodule formation is highlightedwith a black asterisk. Representative images are shown fromhistological
analysis of
3 larvae for each condition from 3 independent experiments. Fb, fat body; GI, gastrointestinal tract; T, trachea. Scale bars, 100 m.
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tivity. However, a functional hemolytic assay for the antifungal
peptide gallysin has been reported (27). Therefore, we assessed
gallysin activity to determine whether the transient inhibition of
antifungal peptide expression was reflected at the protein level.
At 4 h postinoculation, the hemolymph of G. mellonella in-
fected with C. albicans alone had 4.8-fold greater gallysin activity
than control larvae (P 0.05) (Fig. 6C). In contrast, larvae inoc-
ulated withC. albicans plus ACh showed no significant increase in
gallysin activity. Furthermore, in comparison to larvae inoculated
withC. albicans alone, larvae inoculated withC. albicans plus ACh
showed a significant 2.1-fold reduction in gallysin activity (P 
0.01) (Fig. 6C). Twenty-four hours postinoculation, no significant
differences in gallysin activity were observed (Fig. 6C). Therefore,
in agreement with the expression data for gallerimycin and
galiomicin (Fig. 6A andB), ACh can transiently inhibit the activity
of antifungal peptides.
Acetylcholine downregulates Candida albicans-induced he-
molymph lysozyme activity. In addition to antifungal peptides,
we also investigated the effect of ACh on the activity of the anti-
fungal enzyme lysozyme in vivo using an established lysozyme
activity assay (26).
The hemolymph lysozyme activity 4 h postinoculationwas 2.2-
fold greater in larvae inoculated with C. albicans alone than in
PBS-treated control larvae (P 0.05) (Fig. 6D). In contrast, larvae
inoculated with C. albicans plus ACh showed no significant in-
crease in lysozyme activity. Furthermore, in comparison to larvae
inoculated with C. albicans alone, the larvae inoculated with C.
albicans plus ACh showed a significant 2.5-fold reduction in ly-
sozyme activity (P  0.01) (Fig. 6D). Twenty-four hours postin-
oculation, lysozyme activity was 4.9-fold greater in larvae inocu-
lated with C. albicans alone than in the PBS-treated control larvae
(P 0.05) (Fig. 6D).However, in comparison to larvae inoculated
with C. albicans alone, the larvae inoculated with C. albicans plus
ACh showed a significant 1.5-fold reduction in lysozyme activity
(P  0.01) (Fig. 6D). Therefore, ACh has an inhibitory effect on
the activity of the antifungal enzyme lysozyme.
DISCUSSION
Candidiasis has become increasingly recognized as having a bio-
film etiology (21, 29). Recent studies have shown that there is a
positive correlation between biofilm-forming ability and poor
clinical outcomes (30), which is inextricably linked to C. albicans
filamentation (31). In addition, severe C. albicans infection in hu-
mans is associated with sepsis, which causes severe complications
and potentially death (32). Therefore, small molecules that can
inhibit C. albicans biofilm formation, promote rapid cellular im-
mune responses against C. albicans, and at the same time protect
against sepsis are attractive therapeutic options.
This study is the first to report a role for ACh in the pathogen-
esis of C. albicans infection. ACh was found to inhibit C. albicans
biofilm formation both in vitro and in vivo. In vitro analysis
showed that ACh could dose-dependently inhibit biofilm forma-
tion, and the observed effects were not due to cytotoxicity. In vivo
analysis revealed larvae inoculated with C. albicans alone exhib-
FIG 6 Effects of acetylcholine on Galleria mellonella antifungal defenses in vivo. Shown are the effects of ACh on expression of gallerimycin (A) and galiomicin
(B)mRNA. The percentage of expression was determined and compared to that of a housekeeping gene (ACT1) by the 2	CTmethod. Each bar shows themean
and standard deviation from three independent experiments performed on 3 larvae in each group (n 9). (C) Effects of ACh on hemolymph gallysin activity.
Gallysin activity was adjusted for hemocyte number. Each bar shows the mean and standard deviation of corrected hemolytic units of activity from 1 l of
hemolymph from 3 larvae in each group in three independent experiments (n 9). (D) Effects of ACh on hemolymph lysozyme activity. The activity is adjusted
for hemocyte number. Each bar shows the mean and standard deviation of corrected units of activity from 1 l of hemolymph from three independent
experiments performed on 3 G. mellonella larvae in each group (n 9). *, P 0.05; **, P 0.01; and ***, P 0.001.
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ited fungal biofilms in tissues with widespread visceral invasion by
fungal filaments and the formation of large melanized nodules. In
addition, fungal biofilms were commonly observed in vital organs
(gastrointestinal tract and trachea); in line with previous findings
by Borghi et al. (33). In contrast, in larvae inoculated with C.
albicans plus ACh, only yeast cells or stubby hyphae were ob-
served. Furthermore, this was associated with a decrease in fungal
burden and decreased expression of key genes that are important
in biofilm formation, such as HWP1 and ALS3.
In addition to inhibition of C. albicans biofilm formation, in
vivo histological analysis, along with hemocyte counts and cytos-
pin analysis, demonstrated a role for ACh in promoting a rapid
cellular immune response to C. albicans infection. Hemocytes
from larvae inoculated with ACh alone had enhanced adhesion
capabilities, which are associated with activation. However, histo-
logical analysis did not reveal increased numbers of hemocytes in
tissues of larvae inoculated with ACh alone. Therefore, this piece
of data suggested that although ACh can promote hemocyte acti-
vation, the presence of C. albicans in tissues is important for the
recruitment of the activated hemocytes to the site of infection.
Furthermore, evidence for a role of ACh in promoting hemocyte
function is provided by the fact that hemocytes from larvae inoc-
ulated with C. albicans plus ACh formed melanized nodules and
cell monolayers rapidly (both ex vivo and in vivo) and exhibited
enhanced entrapment of C. albicans cells both intracellularly and
extracellularly. Therefore, ACh can promote rapid and effective
immune responses to C. albicans infection in vivo. Interestingly,
however, at 72 h postinoculation, larvae inoculated with C. albi-
cans plus ACh revealed a lack of confluent melanized nodules
accompanied by disaggregation and progressive hemocyte disper-
sion and tissue homeostasis. This was reflected by an increase in
the number of circulating hemocytes. In contrast, hemocytes of
larvae inoculated with C. albicans alone failed to disaggregate and
maintained a dense tissue-like pattern even at 72 h postinocula-
tion. Therefore, this piece of data suggests that ACh promotes a
rapid and effective cellular immune response to clear C. albicans
and possibly prevent inflammation-induced damage of host tis-
sues.
Mousemodels have suggested that AChhas anti-inflammatory
properties, can inhibit the expression of proinflammatory medi-
ators, and can protect against bacterial sepsis (5, 10, 11). G. mel-
lonella has a range of antifungal defense mechanisms that can
protect against C. albicans infection. These include small cationic
and hydrophilic antimicrobial peptides (AMPs) and proteolytic
enzymes. Gallerimycin, galiomicin, gallysin, and lysozyme all have
antifungal activity (34, 35). In this study, AChwas found to have a
transient inhibitory effect on the expression of gallerimycin and
galiomicin and the activity of gallysin. Furthermore, a longer-term
inhibitory effect of ACh on lysozyme activity was also observed.
This piece of data suggested that in line with mammalian models,
ACh can inhibit humoral aspects of innate immunity. The biolog-
ical significance of these findings remains to be elucidated. How-
ever, it is interesting to speculate that this transient inhibition of
humoral innate immunity occurs in order to allow cellular im-
mune responses to clear the infection before the release of an
arsenal of antifungals that may have potential tissue-damaging
bystander effects. Indeed, if this hypothesis is correct, it may also
explain the rapid resolution of inflammation and tissue homeo-
stasis observed 72 h postinfection. However, further research is
required to confirm this hypothesis.
A limitation of this study was that a primitive Galleria mello-
nella infection model was employed instead of mouse models.
However, despite invertebrates being separated by millions of
years of evolution from mammals, many aspects of the innate
immune system are conserved between the species (36). There-
fore, invertebrate models have previously been reported as useful
tools for investigating the early inflammatory events that occur
during infection. Indeed, the Galleria mellonella model has been
successfully reported to model C. albicans virulence, with results
found to be comparable to those of mouse infection models (37).
Another limitation of this study is the fact that at present the
immune cell subtypes that make up the hemocyte population in
Galleria mellonella are still not fully characterized (38). Cytospin
analysis suggested that the predominant immune cells were plas-
matocytes and granulocytes—cells found to have similar charac-
teristics to human neutrophils (38). Neutrophils are host granu-
locytes that protect against microbial infections (39) and control
fungal pathogens by phagocytizing yeast cells and forming neu-
trophil extracellular traps (NETs) in response to hyphae to aid
killing and clearance (40). Interestingly, cytospin analysis sug-
gested that hemocytes organize into NET-like structures and that
this process was promoted by ACh. NET formation has been re-
ported for hemocytes from G. mellonella and has been suggested
to have similarities in appearance and function to vertebrateNETs
(41). The effect of ACh on NET formation in both invertebrates
and higher mammals is currently unknown. However, from the
data described in this article, it is interesting to speculate that ACh
may promote hemocyte activation and NET formation to aid
clearance of C. albicans. In humans, neutrophils express nAChRs
(including7nAChR), and in vitro activation of nAChRs has been
found to promote neutrophil activity by inducing the release of
IL-8 (42), elastase, and prostaglandin E2 (PGE2) (43). Further-
more, activation of nAChRs has been shown to inhibit neutrophil
apoptosis and promote neutrophil survival as well as maturation
(44). Therefore, there is tentative evidence in higher mammals
that ACh may indeed promote neutrophil function. However,
further comprehensive studies are required to confirm this hy-
pothesis.
In conclusion, the data in this article assign two independent
roles for ACh in C. albicans pathogenesis: (i) as an inhibitor of C.
albicans biofilm formation and pathogenicity and (ii) as a regula-
tor of host cellular immune responses to facilitate rapid clearance
ofC. albicans. The novel findings described in this article therefore
suggest that ACh may be a direct or adjunctive therapeutic to
prevent or treat potentially fatal fungal infections.
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